iDD Biotech Overview
- Founded
-
2008

- Status
-
Private
- Latest Deal Type
-
Corporate
- Financing Rounds
-
2
iDD Biotech General Information
Description
Provider of biopharmaceutical services based in Lyon, France. The company offers creation and development of differentiated therapeutic antibodies for the treatment of cancer, infectious diseases, autoimmune diseases, central nervous system diseases.
Contact Information
Website
www.idd-biotech.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
- Accinov building
- 317 avenue Jean Jaurès
- 69007 Lyon
- France
iDD Biotech Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
iDD Biotech Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of biopharmaceutical services based in Lyon, France. The company offers creation and development of differentia
Pharmaceuticals
Lyon, France
00.000
000000000000
00.000
iDD Biotech Competitors (6)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Cipla | Corporation | Mumbai, India | 00000 | 00000000 | ||
0000 00000000 | Formerly VC-backed | Stamford, CT | 00 | 00000 | 000000&0 | 00000 |
000000000000000 | Corporation | Brentford, United Kingdom | 00000 | 000000000 | ||
00000000 | Corporation | Basel, Switzerland | 000000 | 000000000000 | ||
000000 | Formerly PE-Backed | Bangalore, India | 00000 | 000.00 | 00000000 | 000.00 |
iDD Biotech Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Jean-Pierre Lehner | Chairman |
iDD Biotech Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
0000-000000 000000 | iDD Biotech | Chairman | 000 0000 |
iDD Biotech Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|